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The functions of the nervous system can be powerfully modulated by the immune system.
Although traditionally considered to be quite separate, neuro-immune interactions are
increasingly recognized as critical for both normal and pathological nervous system
function in the adult. However, a growing body of information supports a critical role
for neuro-immune interactions before birth, particularly in the prenatal programming of
later-life neurobehavioral disease risk. This review will focus on maternal obesity, as it
represents an environment of pathological immune system function during pregnancy
that elevates offspring neurobehavioral disease risk. We will first delineate the normal
role of the immune system during pregnancy, including the role of the placenta as
both a barrier and relayer of inflammatory information between the maternal and fetal
environments. This will be followed by the current exciting findings of how immuno-
modulatory molecules may elevate offspring risk of neurobehavioral disease by altering
brain development and, consequently, later life function. Finally, by drawing parallels
with pregnancy complications other than obesity, we will suggest that aberrant immune
activation, irrespective of its origin, may lead to neuro-immune interactions that otherwise
would not exist in the developing brain. These interactions could conceivably derail
normal brain development and/or later life function, and thereby elevate risk for obesity
and other neurobehavioral disorders later in the offspring’s life.
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Introduction
The period of life before birth is the most important time in our lives. During this time, develop-
mental mechanisms put into place the cellular foundations on which our functioning, thinking,
and feeling bodies will exist, in sickness and in health, across our lifespan. During the period of
embryonic and fetal development, the mother’s health appears to be absolutely critical to the later
life health of her offspring.
This concept was first appreciated when epidemiological studies examined the long-term health
outcomes of individuals who were in utero during the Dutch hunger winter (1944–1945). The
offspring of these undernourished mothers had low birth weight and impaired glucose tolerance
later in life compared to individuals born in flanking years (Ravelli et al., 1998). Interestingly,
the timing of exposure to famine within the gestational period is also critically important.
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Thus, people exposed to famine in early gestation in the Dutch
hunger winter were at greater risk of developing coronary heart
disease and obesity in later life, whereas those exposed to famine
inmid and late gestation were not similarly affected (Ravelli et al.,
1976; Roseboom et al., 2000). Moreover, impaired glucose toler-
ance in offspring appeared more likely to result from undernu-
trition in late gestation (Ravelli et al., 1998). These observations
inspired the concept that an individual’s risk of disease across
their lifespan could be shaped by events that occurred much ear-
lier in their lives; indeed during their time in the womb (Barker,
2004). With the recent massive increase in obesity across the
western world, much focus has now shifted to understanding
the long-term health outcomes of individuals whose mothers
were obese during pregnancy. Curiously, the epidemiological
data paint a similar picture to undernutrition. Individuals whose
mothers were obese during pregnancy show a significantly higher
risk for later life obesity, and “the metabolic syndrome” (Law
et al., 1992; Gale et al., 2007; Armitage et al., 2008; Crozier et al.,
2010; Tamashiro and Moran, 2010; Alfaradhi and Ozanne, 2011;
Ornoy, 2011). However, they also show increased risk for a con-
stellation of behavioral and mental health problems including
autism, attention deficit/hyperactivity disorder, developmental
delay, anxiety, and depression (Herva et al., 2008; Rodriguez,
2010; Van Lieshout and Boyle, 2011a,b; Colman et al., 2012; Hal-
moy et al., 2012; Krakowiak et al., 2012; Moore et al., 2012;
Wojcik et al., 2013).
Although nutrition during gestation and nutrition after birth
are key contributors to neurobehavioral disease risk across the
lifespan, the mechanisms that link these factors, either alone or
together, to health risks and outcomes remain poorly understood.
Animal models, typically rodent, sheep, or non-human primate
(NHP), have been invaluable in shedding light on the cellular
and molecular details occurring behind the scenes. In these mod-
els, research has traditionally focused on defining the deregulated
function of offspring peripheral organs involved in metabolism,
such as the pancreas, liver, adipose depots, and skeletal muscle
whose function is impaired in obesity and the metabolic syn-
drome. However, since body weight and metabolic function are
regulated by the brain (Stanley and Leibowitz, 1984; Fan et al.,
1997; Cowley et al., 1999; Horvath et al., 1999; Cone et al., 2001;
Elmquist et al., 2005), and since maternal nutrition during preg-
nancy programs an assortment of offspring neurological abnor-
malities, studies examining changes in the offspring brain have
become increasingly prevalent.
In pregnancies complicated by maternal obesity, changes in
the regions of the fetal brain that will regulate body weight
later in life, including the arcuate nucleus of the hypothala-
mus (ARC) and the paraventricular nucleus of the hypothala-
mus (PVN), and brain areas associated with reward and food
seeking have been reported. In the body weight regulating areas,
the adult offspring of obese mothers have been reported to
show: (i) altered expression of the appetite-regulating neuropep-
tides, including agouti-related peptide (AgRP, reduced) and pro-
opiomelanocortin (POMC, reduced), in the ARC; (ii) altered
expression of receptors for appetite-regulating neuropeptides,
including neuropeptide Y (NPY) receptor Y1 and melanocortin
receptor MC4R (both increased), in the PVN; (iii) altered
neurogenesis leading to increased numbers of body weight-
regulating neurons expressing orexin, melanin concentrating
hormone (MCH), galanin, enkephalin, and dynorphin (Chang
et al., 2008; Chen et al., 2009); (iv) ARC neuron leptin resis-
tance, as judged by reduced pSTAT3 in response to exogenous
leptin administration; (v) and developmental alterations in the
neural circuitry that regulates body weight (Bouret et al., 2008;
Kirk et al., 2009; Sanders et al., 2014). In the reward pathways,
there are reports of altered gene expression in the opioid sys-
tem (Grissom et al., 2014), changes in the mesolimbic dopamine
pathways, including increased dopamine synthesis in the nucleus
accumbens (NAc) and ventral tegmental area (VA), and altered
dopamine responsiveness in the NAc accompanied by reduced
dopamine receptor D2 expression in the VTA (Naef et al., 2008,
2011). In the offspring hippocampus, abnormalities have been
observed in neural circuit formation, neurogenesis and cell death
both in the late gestation fetus and in the early post-natal period
(Niculescu and Lupu, 2009; Tozuka et al., 2009, 2010), increased
oxidative stress, and reduced brain derived neurotrophic factor
(BDNF) mRNA and protein (Tozuka et al., 2009, 2010). Such off-
spring also exhibited behavioral changes that are consistent with
the associations between maternal obesity and some aspects of
offspring mental illness observed in humans. For example, the
offspring of obese non-human mothers show defects in spatial
learning in the Barnes maze test (Tozuka et al., 2010), elevated
anxiety (Sasaki et al., 2014), and altered reward seeking behaviors
(Naef et al., 2008, 2011).
Although not comprehensive, the above summary demon-
strates that substantial progress has been, and is being, made
in defining the spectrum of changes that eventuate after birth
when an individual has undergone gestation in an obese mother.
What remains to be discovered is what happens during gesta-
tion, what molecular factors are important, and how they act
on the developing organism to affect the changes that increase
disease risk much later in life. Although many factors could
be at work, the potential importance of the immune system
stands out for two main reasons. Firstly, it has a critical and
highly regulated role at the fetal-maternal interface during nor-
mal pregnancy. Secondly, pregnancies complicated by obesity,
be they human or non-human, are accompanied by elevated
cytokine levels in both the maternal (Catalano et al., 2009;
Madan et al., 2009; Roberts et al., 2011; Kepczynska et al., 2013)
and fetal circulation (Heerwagen et al., 2013; Kim et al., 2014)
across gestation (summarized in Table 1). Moreover, if one con-
siders additional complications of pregnancy that also elevate
offspring risk for metabolic disease and behavioral abnormal-
ities, one feature that they all have in common is abnormal
immune system activation and elevated cytokine levels during
gestation.
The Placenta and Immune System During
Pregnancy
There are multiple changes occurring in a mother’s body during
pregnancy, including increased adiposity and low-grade inflam-
mation (Mor et al., 2011; Zhang et al., 2011). Such dynamic
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TABLE 1 | Summary of inflammatory response in maternal obesity across different species.
Species Source Elevated cytokines Developmental stage
Human Maternal circulation Leptin (Stewart et al., 2007; Challier et al.,
2008; Catalano et al., 2009; Madan et al.,
2009), CRP (Stewart et al., 2007; Challier
et al., 2008; Catalano et al., 2009; Madan
et al., 2009), IL6 (Challier et al., 2008;
Catalano et al., 2009; Roberts et al.,
2011), MCP-1 (Madan et al., 2009)
Second trimester (Madan et al., 2009),
first to third trimester (Stewart et al.,
2007), Pre-labor (Challier et al., 2008;
Catalano et al., 2009), Term (Roberts
et al., 2011)
Placental sample (isolated placental
macrophages)
IL6 (Challier et al., 2008), IL1 (Challier
et al., 2008; Roberts et al., 2011), IL8
(Roberts et al., 2011), TNF (Challier et al.,
2008), MCP1 (Challier et al., 2008)
Term (Challier et al., 2008; Roberts et al.,
2011)
Fetus (umbilical cord blood) Leptin (Catalano et al., 2009), IL6
(Catalano et al., 2009)
Term (Catalano et al., 2009)
Non-human primate Maternal circulation Leptin (Frias et al., 2011) Day 130 (of 170–180 d gestation)(Frias
et al., 2011)
Placental sample MCP1 (Frias et al., 2011), IL1B (Frias
et al., 2011)
Day 130 (of 170–180 d gestation)(Frias
et al., 2011)
Sheep Placental sample TNF (Zhu et al., 2010), IL6 (Zhu et al.,
2010), IL8 (Zhu et al., 2010), IL18 (Zhu
et al., 2010)
Day 75 (of 135 d gestation)(Zhu et al.,
2010)
Mouse Maternal circulation IL1B (Heerwagen et al., 2013; Kim et al.,
2014), IL6 (Heerwagen et al., 2013;
Ingvorsen et al., 2014; Kim et al., 2014),
IL10 (Kim et al., 2014), IFNG (Heerwagen
et al., 2013; Kim et al., 2014), TNF
(Heerwagen et al., 2013; Ingvorsen et al.,
2014; Kim et al., 2014), CXCL1
(Heerwagen et al., 2013), MIP2a
(Heerwagen et al., 2013), CCL25
(Heerwagen et al., 2013), GM-CSF
(Heerwagen et al., 2013), IL2 (Heerwagen
et al., 2013), IL3 (Heerwagen et al., 2013),
IL9 (Heerwagen et al., 2013)
GD15.5 (Kim et al., 2014), GD17.5 (Kim
et al., 2014), GD18.5 (Heerwagen et al.,
2013; Ingvorsen et al., 2014)
Placental sample IL6 (Kim et al., 2014), IL1b (Heerwagen
et al., 2013; Kim et al., 2014), TNF (Kim
et al., 2014), IL10 (Kim et al., 2014), iNOS
(Heerwagen et al., 2013)
GD17.5 (Kim et al., 2014), GD18.5
(Heerwagen et al., 2013)
Fetal circulation IL6 (Kim et al., 2014), IL17A (Kim et al.,
2014), IFNG (Kim et al., 2014)
GD17.5 (Kim et al., 2014)
pregnancy-specific changes are believed, at least in part, to be
responsible for the maternal adaptation to the presence of the
developing fetus. Indeed, the fetus, despite being immunologi-
cally foreign, is not rejected by the maternal immune system. In
mammals, this protection is partly provided by the placenta, a
transient organ that forms at the interface between the mother
and fetus. The placenta is composed of both maternal and fetal
cells and develops upon implantation in humans and early ges-
tation in rodents (Watson and Cross, 2005). Despite the variabil-
ity in placentation across species, placental function is strikingly
similar among most placental mammals (Enders and Blanken-
ship, 1999; Malassine et al., 2003).
Normal Function of the Placenta
One of the most critical functions of the placenta is to act as an
immunological barrier, which protects the fetus from the mater-
nal immune system (Kanellopoulos-Langevin et al., 2003; Mor
et al., 2011). Although the full spectrum of functions that the
placenta performs in its role as an immunological barrier are
not well-understood, current understanding indicates that pla-
cental and decidual immune cells, such as macrophages, have
an immunosuppressive function, and thus dampen the mater-
nal immune response toward the immunologically distinct fetus
(Chang et al., 1993; Lin et al., 1993; Heikkinen et al., 2003;
Gustafsson et al., 2008; Houser et al., 2011; Arck and Hecher,
2013). The placenta can also respond to cytokines (Jones et al.,
2009; Hsiao and Patterson, 2011); and it has been argued that this
serves as a mechanism for relaying information from the mater-
nal environment to the fetus. The ability of maternal cytokines
to cross the placental barrier and directly affect the fetus is still
debatable. Previous studies have shown that some cytokines,
when injected into pregnant rodent dams, are able to cross the
placenta and enter the fetal circulation. Some cytokines have also
been shown to cross the human placenta ex vivo (Zaretsky et al.,
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2004; Dahlgren et al., 2006). This is contrasted, however, by other
studies in humans and rodents, which have demonstrated a lack
of cytokine transport from maternal to fetal circulation (Carbo
et al., 1998; Aaltonen et al., 2005). Reconciling these datasets
will require improved understanding of developmental timing in
order to interweave better our knowledge of the development of
cytokine-specific transport mechanisms in the placenta, chang-
ing cytokine production across gestation (Steinborn et al., 1995,
1998; Mark et al., 2013), and how both cytokine-specific and non-
specific placental permeability change across gestation (Atkinson
et al., 1991; Kent et al., 1994; Dahlgren et al., 2006). Neverthe-
less, what is clear is that the normal placenta, and its resident
immune cells, performs a critical balancing act in order to be both
the barrier and communicator between the mother and fetus.
Altered Placental Function in Maternal Obesity
May Mean Fetal Exposure to Cytokines and
Other Immune System Modulators
Human and animal studies have shown that maternal obesity
alters placental morphology and vascularization (Hayes et al.,
2012; Hayward et al., 2013; Kim et al., 2014). In rodent models of
maternal obesity, decreased layer thickness, reduced trophoblast
proliferation, reduced vascular supply and resultant hypoxia in
the labyrinth were described (Hayes et al., 2012; Kim et al.,
2014). In humans, maternal obesity caused reduced chorionic
plate artery function, which may reduce blood supply to the fetus
(Hayward et al., 2013). In addition, maternal obesity led to pla-
cental inflammation and altered cytokine production in human,
rodent, and ovine models (Challier et al., 2008; Zhu et al., 2010;
Roberts et al., 2011; Kim et al., 2014), including elevation in IL-6,
IL-1β, and TNF production (all models, see Table 1 for com-
plete list and associated animal model), as well as an increase in
infiltrating monocytes and activated macrophages (Challier et al.,
2008; Roberts et al., 2011; Kim et al., 2014). Also, since cytokines
can alter placental nutrient transport, and maternal obesity can
disrupt the placental vascular system (Jones et al., 2009; Hayes
et al., 2012; Hayward et al., 2013), it is likely that fetuses devel-
oping in obese mothers would be exposed to factors from mater-
nal and placental sources that would not be present in a normal
pregnancy.
Evidence for Altered Brain Development
and Offspring Obesity Consequent to
Pathological Cytokine Exposure: A
Common Link?
The idea that inappropriate exposure of the fetal brain to
cytokines can interfere with neural development is an interesting
idea, but has yet to gain traction in the field of developmen-
tal programming by maternal obesity, with currently only one
publication suggesting that inappropriate exposure to inflamma-
tory cytokines specificallymay derail brain development (Sanders
et al., 2014). Thus, we may be well-served to look to other models
of developmental programming for clues to both common and
diverse mechanisms leading to offspring neurobehavioral disor-
ders. If activation of the immune system were to be a shared
causative agent in the offspring programming of metabolic and
mental health disorders, then any pregnancy conditions that
lead to these health outcomes should also exhibit immune sys-
tem activation. Below we briefly review several instances where
the inflammatory environment is changed during gestation, and
where adverse neurobehavioral consequences to the offspring are
observed (summarized in Table 2).
Maternal Immune Activation
Since the late 1980s it has been acknowledged thatmaternal infec-
tion may play a major role in the development of offspring men-
tal illness. Many studies have reported an association between
influenza infection (as well as rubella and respiratory tract infec-
tions) during pregnancy and an increased risk for schizophrenia
and autism spectrum disorders (ASD) in the offspring (Med-
nick et al., 1988; McGrath et al., 1994; Izumoto et al., 1999;
Brown et al., 2001, 2004; Brown, 2006, 2012). However, none
of these epidemiological studies in humans have been able to
prove causation or suggest a mechanism beyond pointing to the
link between maternal immune system activation and adverse
offspring outcomes.
Because very different pathogens seem to cause the same off-
spring phenotype, and since it is unlikely they are able to directly
infect the fetus (Williams andMackenzie, 1977; Irving et al., 2000;
Shi et al., 2005), the maternal immune response has been impli-
cated. Maternal immune activation (MIA) rodent models have
been particularly helpful to examine in more detail the in vivo
effects of the activated maternal immune system on the devel-
oping fetal brain. These models predominantly administer either
bacterial lipopolysaccharide (LPS) or double-stranded viral RNA
mimic polyinosinic:polycytidylic acid (poly I:C) to pregnant rats
or mice. This induces an immune response, and increases cir-
culating levels of multiple cytokines without the confounding
effects of the introduction of a viral or bacterial pathogen itself.
Offspring of these MIA rodents have been reported to show
a “schizophrenic-like” phenotype, including deficits in prepulse
inhibition (PPI), latent inhibition (LI), anxiety, locomotion and
social interaction (Smith et al., 2007; Meyer et al., 2008), as well as
behaviors reminiscent of ASD (Hsiao et al., 2012; Malkova et al.,
2012).
Efforts to tease apart the mechanism have found that the
inflammatory cytokine IL-6 appears to play a significant role
in MIA’s effects on offspring behavioral programming. Inducing
MIA while simultaneously blocking IL-6 actions, via IL-6 recep-
tor deletion or IL-6 function blocking antibody, was able to pre-
vent the ability of MIA to induce a schizophrenic-like phenotype
in offspring (Smith et al., 2007). Additionally, injection of IL-6,
but not the other MIA-induced cytokines IL-1α, tumor necro-
sis factor α (TNFα), or interferon γ (IFNγ), during pregnancy
was enough to cause PPI deficits, a hallmark of schizophrenia, in
offspring (Smith et al., 2007).
There is a curious link between MIA and metabolic disease,
raising the possibility of some shared mechanistic underpin-
nings. Firstly, humans with schizophrenia appear to be more
likely to develop metabolic disease (Ryan et al., 2003; Thakore,
2004; Meyer and Stahl, 2009). In addition, there is some evi-
dence from MIA rodents that metabolic symptoms may also
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TABLE 2 | Summary of different pregnancy states and their metabolic or behavioral sequelae in the offspring.
Maternal state Offspring phenotype Animal models Human data
Maternal infection Neurobehavioral disorders Maternal immune activated (MIA) rodents
produce offspring with schizophrenia and
ASD – like phenotypes (Smith et al.,
2007; Meyer et al., 2008; Hsiao et al.,
2012; Malkova et al., 2012)
Offspring of IL-6 injected rats display a
subset of the MIA phenotype (Smith et al.,
2007)
Maternal influenza, rubella, and
respiratory tract infections during
pregnancy increases offspring risk for
Schizophrenia and ASDs (Williams and
Mackenzie, 1977; Irving et al., 2000;
Smith et al., 2007; Meyer et al., 2008;
Hsiao et al., 2012; Malkova et al., 2012)
Metabolic disease Offspring of MIA and IL-6 injected rodents
display metabolic symptoms (Dahlgren
et al., 2006; Pacheco-López et al., 2011)
IL6 affects fetal hypothalamic circuitry
development (Sanders et al., 2014)
Schizophrenic patients more likely to
develop metabolic disease (Ryan et al.,
2003; Thakore, 2004)
Maternal autoimmune disease Neurobehavioral disorders N/A Maternal autoimmune diseases
associated with increased risk of offspring
neurodevelopmental disorders such as
learning disabilities and ASD (McAllister
et al., 1997; Ross et al., 2003; Neri et al.,
2004)
Metabolic disease N/A Maternal systemic lupus erythematosus
associated with low birthweight – a risk
factor for offspring obesity (Baer et al.,
2011)
Maternal smoking Neurobehavioral disorders Prenatal cigarette exposure mouse model
results in offspring displaying hyperactive
behaviors with disrupted memory
(Balsevich et al., 2014)
Maternal smoking a risk factor for
offspring aggressive behavior, inattention
and conduct disorder, and attention deficit
disorder (Fergusson et al., 1993, 1998;
Orlebeke et al., 1999; Linnet et al., 2003)
Metabolic disease Mice exposed to cigarette smoke during
pregnancy have offspring with increased
body weight and plasma leptin (Chen
et al., 2011)
Maternal smoking predisposes offspring
to obesity in adolescence (Power and
Jefferis, 2002; Al Mamun et al., 2006)
Air pollution exposure Neurobehavioral disorders Offspring of diesel exhaust exposed mice
display decreased locomotion, changes
to dopamine levels, and
neurodevelopmental changes (Hougaard
et al., 2010; Suzuki et al., 2010; Jackson
et al., 2011)
Children exposed in utero to pollutants
from coal fired power plant had motor,
language and social developmental
delays (Tang et al., 2008)
Metabolic disease Offspring of diesel exhaust exposed mice
display increased bodyweight, insulin
resistance particularly on high fat diet
(Bolton et al., 2012)
N/A
result from prenatal immune challenge (Pacheco-López et al.,
2011). Also, injection of IL-6 into pregnant rats can produce off-
spring with increased adipose tissue and body weight (Dahlgren
et al., 2006). Finally, IL-6 appears to affect fetal hypothalamic
neural circuit development in maternal obesity (Sanders et al.,
2014), and has been reported to have many neurotrophic roles
(Spooren et al., 2011). Given these links, it seems plausible
that inflammation, perhaps IL-6 in particular, irrespective of
how it becomes elevated, impinges on fetal brain development.
The big remaining questions relate to whether cytokines have
their effects directly or indirectly on the brain, and/or whether
they cooperate with other cytokines or abnormally elevated fac-
tors to stimulate downstream events that impinge on brain
development.
Maternal Autoimmune Disease
Curiously, the recent increase in obesity prevalence across the
world has been mirrored by a similar rise in autoimmune disease
prevalence. The literature suggests that obesity is a major con-
tributing risk factor for the development of autoimmune disease
in adults. Maternal autoimmune disease represents a spectrum of
maternal disorders in which the fetus is exposed to a proinflam-
matory environment, and where neurobehavioral abnormalities
in the offspring have been identified. For example, childrenwhose
mothers had systemic lupus erythematosus (SLE), had normal
heath and intelligence scores, but a higher rate of learning disabil-
ities such as dyslexia (McAllister et al., 1997; Ross et al., 2003; Neri
et al., 2004). Additionally, primary antiphospholipid syndrome,
is associated with increased risk of ASD and learning disabilities
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in the offspring (Nacinovich et al., 2008; Abisror et al., 2013).
Although there is not yet a retrospective study examining body
weight andmetabolic parameters in the offspring of mothers with
SLE, maternal SLE is associated with babies who are small for ges-
tational age (Baer et al., 2011), itself a risk factor for developing
obesity later in life (Barker, 2006; Gluckman et al., 2008).
Maternal Smoking
Maternal cigarette smoking, in addition to its direct effects on
maternal and fetal health, predisposes offspring to increased risk
of several later life adverse neurobehavioral outcomes, including
aggressive behavior (Orlebeke et al., 1999), inattention and con-
duct disorder (Fergusson et al., 1993, 1998), and attention deficit
disorder (Linnet et al., 2003). Animal models of prenatal cigarette
smoke exposure have reported behavioral changes in adult off-
spring which parallel these human disorders (Balsevich et al.,
2014). Further to this, maternal smoking is also associated with
increased risk of obesity and the metabolic syndrome in the off-
spring, which show increased plasma leptin and impaired glucose
tolerance in both humans and animal models (Power and Jefferis,
2002; AlMamun et al., 2006; Chen et al., 2011). Although it can be
difficult to tease apart the various effects of smoking during preg-
nancy, and exposure during early postnatal life, observations cur-
rently suggest a critical prenatal window during the first trimester
of human pregnancy as the time when smoking is most likely to
confer adverse health outcomes on the offspring (Toschke et al.,
2003; Oken et al., 2005; Al Mamun et al., 2006).
Here, as with other complications of pregnancy that lead to
developmental programming of neurobehavioral and metabolic
disorders in the offspring, there appears to be chronic inflamma-
tion with elevated cytokines and other markers of immune sys-
tem activation during gestation (Bermudez et al., 2002; Yanbaeva
et al., 2007; Gosker et al., 2009).
Air Pollution
Human studies have found that children exposed in utero to
pollutants from a nearby coal fired power plant had motor, lan-
guage and social developmental delays (Tang et al., 2008). Ani-
mal models have shown that the air pollution present in modern
day cities could cause a proinflammatory state during pregnancy,
and increase the risk of metabolic and psychological disorders in
the offspring. Pregnant mice exposed to common nanoparticle
pollutants or diesel exhaust, showed elevated proinflammatory
cytokines including IL-1β and IL-6, some of which were detected
in the fetal brain (Hougaard et al., 2010; Bolton et al., 2012; Jack-
son et al., 2012). The offspring of mice exposed to diesel exhaust
displayed decreased locomotion, changes in the levels of the neu-
rotransmitter dopamine, and neurobehavioral changes, including
a tendency to avoid the central zone in an open field test and
enhanced prepulse inhibition (Hougaard et al., 2010; Suzuki et al.,
2010; Jackson et al., 2011). In addition, these offspring showed
increased body weight and insulin resistance, classic features of
the metabolic syndrome, particularly when placed on a high-fat
diet (Bolton et al., 2012).
Taking these events or exposures together with their effects
on cytokine abundance and offspring outcomes, it is tempt-
ing to speculate that abnormal exposure of the fetus to
immuno-modulatory molecules is the critical element linking
adverse pregnancy experiences with developmental program-
ming of obesity and neurobehavioral risks for the offspring.
How Might Immuno-Modulatory Molecules
Elevate Offspring Risk of Neurobehavioral
Disease?
Many of the changes to offspring phenotype that result from pre-
natal cytokine exposure are likely to be underpinned by changes
in brain function, including cellular physiology, neural connec-
tivity, and gene expression. The consequences are that the off-
spring’s neural control of body weight and behavior are perturbed
and/or are less robust to environmental challenge. How prenatal
exposure affects later-life function is an area of much interest, but
currently very fewmechanisms have been revealed to explain this
curious relationship. One possibility is that prenatal brain devel-
opment is altered by abnormal exposure to cytokines, leading
to structural changes in the brain that might underpin subopti-
mal function. Another is that abnormal cytokine exposure during
fetal life alters the epigenetic regulation of genes whose expres-
sion and regulation later in life is critical to appropriate body
weight regulation and behavior. These options and their potential
consequences to the later life ability of the brain to regulate body
weight are summarized in Figure 1. Similar mechanisms might
be invoked to account for other abnormal offspring behaviors,
such as socialization and learning, consequent to maternal obe-
sity; and in these cases brain areas outside hypothalamic feeding
centers (e.g., those that regulate the behaviors in question) are
likely to be affected.
Access of Cytokines to the Fetal Brain
During normal development, the embryonic and fetal brain are
believed to have limited exposure to cytokines because either
their circulating levels are low (early pregnancy), or because entry
into the brain is regulated (mid-late pregnancy). The blood-brain
barrier (BBB) is believed to become functional between GD15
and GD17 in the mouse (Ben-Zvi et al., 2014). This time is theo-
rized to relate approximately to late second/early third trimester
in the human, but the actual time of BBB formation in humans
is not well-characterized. Thus, prior to BBB formation, if there
were elevated cytokines in the fetal circulation they might sim-
ply diffuse into the developing brain. Later in gestation, early life
and into adulthood, when the BBB is intact, the main route into
the brain for blood-borne molecules is via specific transporters
that move molecules, including leptin, insulin, and growth fac-
tors, from the blood into the brain (Pohl et al., 2013; Banks,
2015; Koch et al., 2014). Some molecules may also enter the
brain via fenestrated capillaries in circumventricular organs or
the choroid plexus. Howmolecules that pass through the choroid
plexus endothelium and into the ventricles then pass into the
brain parenchyma are not well-characterized, but transporters as
well as transcellular signaling have been implicated (Balland et al.,
2014). The time in development at which the genes encoding
these transporters begin to be expressed is currently unknown,
but abnormally elevated cytokines might gain access to the fetal
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brain through these normal transport mechanisms. Perturbation
of either BBB formation or transporter function/gene expression
in the brains of offspring developing in obese mothers are inter-
esting further possible mechanisms that could account for abnor-
mal exposure of the fetal brain to elevated cytokines. Another
possible source of cytokines in the developing brain aremicroglia.
These brain-resident immune cells of the monocyte lineage, are
generated in the yolk sac around GD10, and can be found in the
fetal brain several days later (Saijo and Glass, 2011). These seem
likely candidates for producing cytokines within the brain proper,
but they would need to become activated before they could do
so. In support of this, recent evidence from the non-human pri-
mate suggests that microglia become abnormally activated in the
prenatal hypothalamus of fetuses developing in high-fat diet-fed
mothers (Grayson et al., 2010). These same fetuses also showed
elevated cytokine gene expression in the hypothalamus, indicat-
ing that resident cells, such as activated microglia, provided an
endogenous source of cytokines (Grayson et al., 2010).
Direct Effects of Cytokines on the Developing
Brain
Although there is no apparent role for immune system-derived
cytokines in normal brain development, the activation of
cytokine signal transduction pathways, including JAK-STAT and
MEK/ERK, are well-known to modulate brain development,
including neurogenesis, cell type specification, migration, and
axon growth (Schwarting et al., 2006; Markham et al., 2007; Qin
and Zhang, 2012; Lee et al., 2013; Urayama et al., 2013). Thus,
should cytokines gain access to the fetal brain inappropriately,
they have the potential for substantial interference with normal
neural development (Figure 1). Should such a mechanism be
occurring, it is predicted that individuals who were exposed to
cytokines in utero, would show structural changes in their brains
at birth. In both humans and animal models, there are numerous
reports of offspring brain changes that are evident beyond the
neonatal period and in adulthood. However, few studies report
structural or other alterations in the brain that are evident at
birth, and which are related either to pregnancy complications
or later-life outcomes. On the day of birth in a mouse model of
gestational obesity, the neural network regulating body weight is
malformed in the offspring’s brain, with fewer neural projections
from the ARC reaching their targets (Sanders et al., 2014). Fur-
ther exploration of the underlying mechanism revealed a role for
IL-6, which altered axon growth and underlying developmental
gene expression (Sanders et al., 2014). Also evident on the day
of birth in a rat model of maternal obesity, were: (i) increases in
the expression of orexigenic peptides, orexin and melanin con-
centrating hormone, in the lateral hypothalamic area; and (ii)
increased galanin, enkephalin, and dynorphin expression in the
PVN (Chang et al., 2008). Further exploration of the underlying
mechanism revealed altered neurogenesis, leading to an increase
in the generation of these cell types in the brains of fetuses devel-
oping in obese mothers (Chang et al., 2008). Also in a rat model
of maternal obesity, CD11b and TLR4, both markers of activated
microglia, were elevated on the day of birth (Bilbo and Tsang,
2010). This further suggests the possibility of an inflammatory
state during the prenatal period. Better defining brain abnormal-
ities as having their origins during prenatal or postnatal develop-
ment (or some elements of each) will be critical to understanding
underlying mechanisms, and ongoing research is beginning to
provide this key information.
Effects of Cytokines on Epigenetic Regulators
Another possibility is that genes whose expression is critical for
later life neural function are epigenetically modified at the time of
cytokine exposure. Such genes may not necessarily be expressed
during gestation, but the epigenetic marks laid down before birth
would be there to affect gene expression whenever such genes
were needed for normal neural function later in life; should such
changes alter normal neural function, disease risk would be ele-
vated. There is no need for the two mechanisms to be mutu-
ally exclusive (or exclusive of other possibilities), so it is likely
that multiple mechanisms are at play when a fetus develops in
an environment complicated by inappropriate cytokine exposure
(Figure 1).
In many cases where life experience is associated with phe-
notypic change, alterations in DNA methylation, histone mod-
ifications, regulatory RNAs or some combination thereof have
FIGURE 1 | Mechanisms by which inappropriate cytokine exposure
may alter later life brain function. Schematic indicates that cytokine
exposure could result in immediate non-genomic (e.g., via kinase cascades)
or genomic (e.g., change in transcription factor activity) effects on the
developing brain. Cytokine exposure may also initiate activity of enzymes that
catalyze epigenetic modifications, which could have immediate or long-term
consequences on gene expression. The output of such cytokine exposure
would be disrupted adult function, such that neural mechanisms regulating
body weight do not function optimally, and thus give rise to a risk of
obesity.
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been observed inmultiple offspring tissues.What we currently do
not understand in relation to maternal obesity is: which environ-
mental factors are important modulators of the molecules that
execute epigenetic changes; how particular genes become tar-
geted for epigenetic change by certain factors; and how a constel-
lation of epigenetic modifications occurring across the genome
affect gene function at discrete loci and at particular times during
development and adult life.
Should cytokines be causative agents in developmental pro-
gramming via an epigenetic mechanism, then they should be
able to modulate the activity of the proteins that enact epige-
netic change, but how they might do so is less clear. It is known
from cancer studies that inflammation-induced DNA methyla-
tion and histone changes are associated with polycomb-group
target genes, which are significant here because their regula-
tion relies on chromatin remodeling (Hahn et al., 2008). Also in
cancer cell lines, IL-6 is able to affect both the expression and
nuclear translocation of DNA methyltransferase 1 (DNMT1),
consequently changing its activity within the cell (Hodge et al.,
2001, 2007; Foran et al., 2010), and potentially targeting methyla-
tion to specific gene promoter regions (Li et al., 2012). As many
epigenetic modifying enzymes are regulated by phosphorylation
cascades (Jeltsch and Jurkowska, 2014), and since cytokines are
known to stimulate multiple kinase cascades, including ERK, Jnk,
PI3 kinase/Akt (Hirano et al., 1997; Mak and Yeh, 2002; Pestka
et al., 2004a,b), the mechanistic links seem apparent, and avail-
able for further testing. In addition, transcription factors play a
key role in directing epigenetic changes to particular genomic
regions (Ding et al., 2008; Hashimoto et al., 2010; Feldmann et al.,
2013). Cytokines also notoriously signal through the JAK/STAT
pathway, which leads to DNA binding and transcriptional modu-
lation by the activated STAT proteins (Murray, 2007). STAT pro-
teins already have been described for their ability to recruit DNA
binding and transcriptional regulatorymolecules to specific DNA
sequences, so this represents another signaling pathway through
which cytokine exposure could lead to epigenetic modifications
across the genome (Vahedi et al., 2012; Hedrich et al., 2014; Li
et al., 2014).
Can Anti-Inflammation Treatment Protect
the Offspring Brain?
If abnormally elevated inflammatory mediators play a causative
role in the acquisition of offspring phenotype, then ameliorat-
ing them should protect normal offspring physiology. This line
of reasoning has been used to test the efficacy of a number of
pharmacological and physiological strategies that reduce inflam-
mation. The literature here is growing rapidly, and this section
is not intended to be exhaustive, but rather to give a glimpse
into where the field is headed, and to bolster the hypothesis
that increased exposure of the developing brain to inflammatory
mediators is a key player in the developmental programming of
offspring neurobehavioral disorders, including deregulated body
weight control.
Transgenic elevation of the anti-inflammatory n-3 polyun-
saturated fatty acids (PUFA) relative to the pro-inflammatory
n-6-PUFAs in a mouse model of maternal obesity, reduced the
metabolic phenotype of offspring, including normalizing liver
triglycerides and insulin sensitivity, and reducing body weight
(Heerwagen et al., 2013). Unfortunately, inflammatory markers
were not examined in the brain. As the transgene would presum-
ably have been active during development, then it is likely that
an anti-inflammatory milieu during gestation played a key role
in determining the offspring phenotype, however, this was not
examined directly. Several other agents with broad effects includ-
ing anti-inflammatory, such as resveratrol (Roberts et al., 2014)
and taurine (Li et al., 2013), have also been trialed in non-human
primate or rat models of maternal obesity, respectively. Both
reported mixed effects and confounding details that limit their
practical utility, and neither examined inflammation in the brain.
Manipulation of diet and exercise also have been used to tar-
get inflammation as ameans to combat offspring consequences of
maternal obesity. Reversingmaternal diet from high fat to control
during the lactation period and after weaning in a mouse model
of maternal obesity, was able to reverse social deficits and brain
inflammation in offspring (Kang et al., 2014). This suggests that
the neural circuits regulating social behavior rely on a constant
exposure, particularly in the neonatal period, to inflammatory
mediators in order to form and/or function improperly later in
life. At least some of the neural circuits governing social behaviors
show a great deal of plasticity in the early postnatal period, sug-
gesting that once inflammation is reduced, these brain areas have
the ability to form/reform normally. Other brain areas, governing
other behaviors, will likely have different schedules of develop-
ment and plasticity. Identifying these opportune times for plas-
ticity will be critical to applying anti-inflammatory interventions
to reduce offspring metabolic disease.
Exercise is another intervention that has been used to reverse
the effects of maternal obesity on offspring health. Although exer-
cise has been used to combat a variety of health disorders, the
mechanisms underlying its effects are not well-understood. In a
rat model of maternal obesity, several studies have observed that
exercise, in either the early postnatal period or adulthood, was
able to improve the offspring metabolic dysfunction caused by
maternal obesity (Bahari et al., 2013; Rajia et al., 2013). The effects
of early life voluntary exercise have not examined inflammatory
marker expression in the brain (Rajia et al., 2013). Exercise in the
adult offspring of obese dams who received either control or high
fat diet after weaning showed a trend toward reduced IL-6mRNA
levels in the ARC and IL-1β in the hippocampus following exer-
cise compared to animals with similar diet history, but no exercise
(Bahari et al., 2013).
Conclusions
Although the causative factors that link pregnancy complications
or exposures to offspring health and disease risks later in life
have yet to be fully cataloged, cytokines, classically known for
their roles in immune system modulation, are surfacing as key
players. Doubtless there are many more factors remaining to be
identified. In addition, the mechanisms by which such factors
impinge on the developing fetal brain and other organs remain
very poorly explored at present. Identifying these mechanisms
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and linking them causally with later life disease susceptibility
will be a monumental challenge. Such understanding, however, is
critical to developing therapeutic approaches to protect the devel-
oping brain in the face of adverse pregnancy complications. Of
important further consideration, is the role of factors, including
those from the immune system, in the postnatal developmen-
tal period, where the brain’s extensive plasticity could be har-
nessed. The body of literature in this area also is growing at a
rapid pace, and the interplay among prenatal and postnatal fac-
tors, immune activation, and brain development and function
later in life are well on their way to being more clearly defined.
The next great challenges will be to translate this mechanis-
tic understanding into preventative and directed interventions
aimed at reducing the burden of disease risk that stems from
pregnancy complications and exposures that are not currently
easily preventable.
Acknowledgment
This work was funded by the University of Otago, the Maurice
and Phyllis Paykel Trust NewZealand, andGravida: NewZealand
National Centre for Growth and Development.
References
Aaltonen, R., Heikkinen, T., Hakala, K., Laine, K., and Alanen, A. (2005). Trans-
fer of proinflammatory cytokines across term placenta. Obstet. Gynecol. 106,
802–807. doi: 10.1097/01.AOG.0000178750.84837.ed
Abisror, N., Mekinian, A., Lachassinne, E., Nicaise-Roland, P., De Pontual, L.,
Chollet-Martin, S., et al. (2013). Autism spectrum disorders in babies born
to mothers with antiphospholipid syndrome. Semin. Arthritis Rheum. 43,
348–351. doi: 10.1016/j.semarthrit.2013.07.001
Alfaradhi, M. Z., and Ozanne, S. E. (2011). Developmental program-
ming in response to maternal overnutrition. Front. Genet. 2:27. doi:
10.3389/fgene.2011.00027
Al Mamun, A., Lawlor, D. A., Alati, R., O’Callaghan, M. J., Williams, G.
M., and Najman, J. M. (2006). Does maternal smoking during pregnancy
have a direct effect on future offspring obesity? evidence from a prospec-
tive birth cohort study. Am. J. Epidemiol. 164, 317–325. doi: 10.1093/aje/
kwj209
Arck, P. C., and Hecher, K. (2013). Fetomaternal immune cross-talk and its con-
sequences for maternal and offspring’s health. Nat. Med. 19, 548–556. doi:
10.1038/nm.3160
Armitage, J. A., Poston, L., and Taylor, P. D. (2008). Developmental origins of obe-
sity and themetabolic syndrome: the role of maternal obesity. Front. Horm. Res.
36, 73–84. doi: 10.1159/000115355
Atkinson, D. E., Robinson, N. R., and Sibley, C. P. (1991). Development of passive
permeability characteristics of rat placenta during the last third of gestation.
Am. J. Physiol. 261(6 Pt 2), R1461–R1464.
Baer, A. N., Witter, F. R., and Petri, M. (2011). Lupus and pregnancy. Obstet.
Gynecol. Surv. 66, 639–653. doi: 10.1097/OGX.0b013e318239e1ee
Bahari, H., Caruso, V., and Morris, M. J. (2013). Late-onset exercise in female
rat offspring ameliorates the detrimental metabolic impact of maternal obesity.
Endocrinology 154, 3610–3621. doi: 10.1210/en.2013-1059
Balland, E., Dam, J., Langlet, F., Caron, E., Steculorum, S., Messina, A., et al. (2014).
Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell
Metab. 19, 293–301. doi: 10.1016/j.cmet.2013.12.015
Balsevich, G., Poon, A., Goldowitz, D., and Wilking, J. A. (2014). The effects of
pre- and post-natal nicotine exposure and genetic background on the stria-
tum and behavioral phenotypes in the mouse. Behav. Brain Res. 266, 7–18. doi:
10.1016/j.bbr.2014.02.038
Banks, W. A. (2015). The blood-brain barrier in neuroimmunology: tales
of separation and assimilation. Brain Behav. Immun. 44C, 1–8. doi:
10.1016/j.bbi.2014.08.007
Barker, D. J. (2004). The developmental origins of chronic adult disease. Acta
Paediatr. Suppl. 93, 26–33. doi: 10.1111/j.1651-2227.2004.tb00236.x
Barker, D. J. (2006). Adult consequences of fetal growth restriction. Clin. Obstet.
Gynecol. 49, 270–283. doi: 10.1097/00003081-200606000-00009
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., et al. (2014).
Mfsd2a is critical for the formation and function of the blood-brain barrier.
Nature 509, 507–511. doi: 10.1038/nature13324
Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., and Ridker, P. M.
(2002). Relation betweenmarkers of systemic vascular inflammation and smok-
ing in women. Am. J. Cardiol. 89, 1117–1119. doi: 10.1016/S0002-9149(02)
02284-1
Bilbo, S. D., and Tsang, V. (2010). Enduring consequences of maternal obesity
for brain inflammation and behavior of offspring. FASEB J. doi: 10.1096/fj.09-
144014
Bolton, J. L., Smith, S. H., Huff, N. C., Gilmour, M. I., Foster, W. M., Auten, R.
L., et al. (2012). Prenatal air pollution exposure induces neuroinflammation
and predisposes offspring to weight gain in adulthood in a sex-specific manner.
FASEB J. 26, 4743–4754. doi: 10.1096/fj.12-210989
Bouret, S. G., Gorski, J. N., Patterson, C. M., Chen, S., Levin, B. E., and Simerly, R.
B. (2008). Hypothalamic neural projections are permanently disrupted in diet-
induced obese rats. Cell Metab. 7, 179–185. doi: 10.1016/j.cmet.2007.12.001
Brown, A. S. (2006). Prenatal infection as a risk factor for schizophrenia. Schizophr.
Bull. 32, 200–202. doi: 10.1093/schbul/sbj052
Brown, A. S. (2012). Epidemiologic studies of exposure to prenatal infection
and risk of schizophrenia and autism. Dev. Neurobiol. 72, 1272–1276. doi:
10.1002/dneu.22024
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bres-
nahan, M., et al. (2004). Serologic-evidence of prenatal influenza in the
etiology of schizophrenia.Arch. Gen. Psychiatry 61, 774–780. doi: 10.1001/arch-
psyc.61.8.774
Brown, A. S., Cohen, P., Harkavy-Friedman, J., Babulas, V., Malaspina, D.,
Gorman, J. M., et al. (2001). Prenatal rubella, premorbid abnormalities,
and adult schizophrenia. Biol. Psychiatry 49, 473–486. doi: 10.1016/S0006-
3223(01)01068-X
Carbo, N., Lopez-Soriano, F. J., and Argiles, J. M. (1998). Tumour necrosis
factor-alpha does not cross the rat placenta. Cancer Lett. 128, 101–104. doi:
10.1016/S0304-3835(98)00057-3
Catalano, P. M., Presley, L., Minium, J., and Hauguel-De Mouzon, S. (2009).
Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 32,
1076–1080. doi: 10.2337/dc08-2077
Challier, J. C., Basu, S., Bintein, T., Minium, J., Hotmire, K., Catalano,
P. M., et al. (2008). Obesity in pregnancy stimulates macrophage accu-
mulation and inflammation in the placenta. Placenta 29, 274–281. doi:
10.1016/j.placenta.2007.12.010
Chang, G. Q., Gaysinskaya, V., Karatayev, O., and Leibowitz, S. F. (2008).
Maternal high-fat diet and fetal programming: increased proliferation of
hypothalamic peptide-producing neurons that increase risk for overeating
and obesity. J. Neurosci. 28, 12107–12119. doi: 10.1523/JNEUROSCI.2642-
08.2008
Chang, M. D., Pollard, J. W., Khalili, H., Goyert, S. M., and Diamond, B. (1993).
Mouse placental macrophages have a decreased ability to present antigen. Proc.
Natl. Acad. Sci. U.S.A. 90, 462–466. doi: 10.1073/pnas.90.2.462
Chen, H., Iglesias, M. A., Caruso, V., and Morris, M. J. (2011). Maternal cigarette
smoke exposure contributes to glucose intolerance and decreased brain insulin
action in mice offspring independent of maternal diet. PLoS ONE 6:e27260. doi:
10.1371/journal.pone.0027260
Chen, H., Simar, D., and Morris, M. J. (2009). Hypothalamic neuroendocrine
circuitry is programmed by maternal obesity: interaction with postnatal nutri-
tional environment. PLoS ONE 4:e6259. doi: 10.1371/journal.pone.0006259
Colman, I., Ataullahjan, A., Naicker, K., and Van Lieshout, R. J. (2012). Birth
weight, stress, and symptoms of depression in adolescence: evidence of
fetal programming in a national Canadian cohort. Can. J. Psychiatry 57,
422–428.
Frontiers in Neuroscience | www.frontiersin.org 9 February 2015 | Volume 8 | Article 455
Jasoni et al. Gestational inflammation programs disease risk
Cone, R. D., Cowley, M. A., Butler, A. A., Fan, W., Marks, D. L., and Low, M. J.
(2001). The arcuate nucleus as a conduit for diverse signals relevant to energy
homeostasis. Int. J. Obes. Relat. Metab. Disord. 25(Suppl. 5), S63–S67. doi:
10.1038/sj.ijo.0801913
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., and
Cone, R. D. (1999). Integration of NPY, AGRP, and melanocortin signals in
the hypothalamic paraventricular nucleus: evidence of a cellular basis for the
adipostat. Neuron 24, 155–163. doi: 10.1016/S0896-6273(00)80829-6
Crozier, S. R., Inskip, H. M., Godfrey, K. M., Cooper, C., Harvey, N. C.,
Cole, Z. A., et al. (2010). Southampton Women’s Survey Study Group.
Weight gain in pregnancy and childhood body composition: findings from
the Southampton Women’s Survey. Am. J. Clin. Nutr. 91, 1745–1751. doi:
10.3945/ajcn.2009.29128
Dahlgren, J., Samuelsson, A.-M., Jansson, T., and Holmang, A. (2006). Interleukin-
6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr. Res.
60, 147–151. doi: 10.1203/01.pdr.0000230026.74139.18
Ding, N., Zhou, H., Esteve, P. O., Chin, H. G., Kim, S., Xu, X., et al. (2008). Media-
tor links epigenetic silencing of neuronal gene expression with x-linked mental
retardation.Mol. Cell 31, 347–359. doi: 10.1016/j.molcel.2008.05.023
Elmquist, J. K., Coppari, R., Balthasar, N., Ichinose, M., and Lowell, B. B. (2005).
Identifying hypothalamic pathways controlling food intake, body weight, and
glucose homeostasis. J. Comp. Neurol. 493, 63–71. doi: 10.1002/cne.20786
Enders, A. C., and Blankenship, T. N. (1999). Comparative placental structure.
Adv. Drug Deliv. Rev. 38, 3–15. doi: 10.1016/S0169-409X(99)00003-4
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., and Cone, R. D. (1997).
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Nature 385, 165–168. doi: 10.1038/385165a0
Feldmann, A., Ivanek, R., Murr, R., Gaidatzis, D., Burger, L., and Schubeler, D.
(2013). Transcription factor occupancy can mediate active turnover of DNA
methylation at regulatory regions. PLoS Genet. 9:e1003994. doi: 10.1371/jour-
nal.pgen.1003994
Fergusson, D. M., Horwood, L. J., and Lynskey, M. T. (1993). Maternal smok-
ing before and after pregnancy: effects on behavioral outcomes in middle
childhood. Pediatrics 92, 815.
Fergusson, D. M., Woodward, L. J., and Horwood, L. (1998). Maternal smoking
during pregnancy and psychiatric adjustment in late adolescence. Arch. Gen.
Psychiatry 55, 721–727. doi: 10.1001/archpsyc.55.8.721
Foran, E., Garrity-Park, M. M., Mureau, C., Newell, J., Smyrk, T. C., Limburg, P. J.,
et al. (2010). Upregulation of DNA methyltransferase–mediated gene silenc-
ing, anchorage-independent growth, and migration of colon cancer cells by
interleukin-6. Mol. Cancer Res. 8, 471–481. doi: 10.1158/1541-7786.MCR-09-
0496
Frias, A. E., Morgan, T. K., Evans, A. E., Rasanen, J., Oh, K. Y., Thornburg,
K. L., et al. (2011). Maternal high-fat diet disturbs uteroplacental hemo-
dynamics and increases the frequency of stillbirth in a nonhuman pri-
mate model of excess nutrition. Endocrinology 152, 2456–2464. doi: 10.1210/
en.2010-1332
Gale, C. R., Javaid, M. K., Robinson, S. M., Law, C. M., Godfrey, K. M., and Cooper,
C. (2007).Maternal size in pregnancy and body composition in children. J. Clin.
Endocrinol. Metab. 92, 3904–3911. doi: 10.1210/jc.2007-0088
Gluckman, P. D., Hanson, M. A., Cooper, C., and Thornburg, K. L. (2008). Effect
of in utero and early-life conditions on adult health and disease.N. Engl. J. Med.
359, 61–73. doi: 10.1056/NEJMra0708473
Gosker, H. R., Langen, R. C. J., Bracke, K. R., Joos, G. F., Brusselle, G. G., Steele, C.,
et al. (2009). Extrapulmonary manifestations of chronic obstructive pulmonary
disease in a mouse model of chronic cigarette smoke exposure. Am. J. Respir.
Cell Mol. Biol. 40, 710–716. doi: 10.1165/rcmb.2008-0312OC
Grayson, B. E., Levasseur, P. R., Williams, S. M., Smith, M. S., Marks, D. L.,
and Grove, K. L. (2010). Changes in melanocortin expression and inflamma-
tory pathways in fetal offspring of nonhuman primates fed a high-fat diet.
Endocrinology 151, 1622–1632. doi: 10.1210/en.2009-1019
Grissom, N. M., Lyde, R., Christ, L., Sasson, I. E., Carlin, J., Vitins, A. P., et al.
(2014). Obesity at conception programs the opioid system in the offspring
brain. Neuropsychopharmacology 39, 801–810. doi: 10.1038/npp.2013.193
Gustafsson, C., Mjosberg, J., Matussek, A., Geffers, R., Matthiesen, L., Berg, G., et al.
(2008). Gene expression profiling of human decidual macrophages: evidence
for immunosuppressive phenotype. PLoS ONE 3:e2078. doi: 10.1371/jour-
nal.pone.0002078
Hahn, M. A., Hahn, T., Lee, D. H., Esworthy, R. S., Kim, B. W., Riggs, A. D., et al.
(2008). Methylation of polycomb target genes in intestinal cancer is mediated
by inflammation. Cancer Res. 68, 10280–10289. doi: 10.1158/0008-5472.CAN-
08-1957
Halmoy, A., Klungsoyr, K., Skjaerven, R., and Haavik, J. (2012). Pre- and peri-
natal risk factors in adults with attention-deficit/hyperactivity disorder. Biol.
Psychiatry 71, 474–481. doi: 10.1016/j.biopsych.2011.11.013
Hashimoto, H., Vertino, P. M., and Cheng, X. (2010). Molecular coupling of
DNA methylation and histone methylation. Epigenomics 2, 657–669. doi:
10.2217/epi.10.44
Hayes, E. K., Lechowicz, A., Petrik, J. J., Storozhuk, Y., Paez-Parent, S., Dai, Q.,
et al. (2012). Adverse fetal and neonatal outcomes associated with a life-long
high fat diet: role of altered development of the placental vasculature. PLoSONE
7:e33370. doi: 10.1371/journal.pone.0033370
Hayward, C. E., Higgins, L., Cowley, E. J., Greenwood, S. L., Mills, T. A., Sibley, C.
P., et al. (2013). Chorionic plate arterial function is altered in maternal obesity.
Placenta 34, 281–287. doi: 10.1016/j.placenta.2013.01.001
Hedrich, C. M., Rauen, T., Apostolidis, S. A., Grammatikos, A. P., Rodriguez
Rodriguez, N., Ioannidis, C., et al. (2014). Stat3 promotes IL-10 expression in
lupus T cells through trans-activation and chromatin remodeling. Proc. Natl.
Acad. Sci. U.S.A. 111, 13457–13462. doi: 10.1073/pnas.1408023111
Heerwagen, M. J., Stewart, M. S., De La Houssaye, B. A., Janssen, R. C., and Fried-
man, J. E. (2013). Transgenic increase in N-3/n-6 Fatty Acid ratio reduces
maternal obesity-associated inflammation and limits adverse developmen-
tal programming in mice. PLoS ONE 8:e67791. doi: 10.1371/journal.pone.
0067791
Heikkinen, J., Mottonen, M., Komi, J., Alanen, A., and Lassila, O. (2003). Pheno-
typic characterization of human decidual macrophages. Clin. Exp. Immunol.
131, 498–505. doi: 10.1046/j.1365-2249.2003.02092.x
Herva, A., Pouta, A., Hakko, H., Laksy, K., Joukamaa, M., and Veijola, J. (2008).
Birth measures and depression at age 31 years: the Northern Finland 1966
Birth Cohort Study. Psychiatry Res. 160, 263–270. doi: 10.1016/j.psychres.2007.
07.020
Hirano, T., Nakajima, K., and Hibi, M. (1997). Signaling mechanisms through
gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241–252.
doi: 10.1016/S1359-6101(98)80005-1
Hodge, D. R., Cho, E., Copeland, T. D., Guszczynski, T., Yang, E., Seth, A. K.,
et al. (2007). IL-6 enhances the nuclear translocation of DNA cytosine-5-
methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization
sequence by the AKT kinase. Cancer Genomics Proteomics 4, 387–398.
Hodge, D. R., Xiao, W., Clausen, P. A., Heidecker, G., Szyf, M., and Far-
rar, W. L. (2001). Interleukin-6 regulation of the human DNA methyltrans-
ferase (HDNMT) gene in human erythroleukemia cells. J. Biol. Chem. 276,
39508–39511. doi: 10.1074/jbc.C100343200
Horvath, T. L., Diano, S., and Van Den Pol, A. N. (1999). Synaptic interaction
between hypocretin (orexin) and neuropeptide Y cells in the rodent and pri-
mate hypothalamus: a novel circuit implicated in metabolic and endocrine
regulations. J. Neurosci. 19, 1072–1087.
Hougaard, K. S., Jackson, P., Jensen, K. A., Sloth, J. J., Löschner, K., Larsen,
E. H., et al. (2010). Effects of prenatal exposure to surface-coated nanosized
titanium dioxide (UV-Titan). A study in mice. Part. Fibre Toxicol. 7:16. doi:
10.1186/1743-8977-7-16
Houser, B. L., Tilburgs, T., Hill, J., Nicotra, M. L., and Strominger, J. L. (2011). Two
unique human decidual macrophage populations. J. Immunol. 186, 2633–2642.
doi: 10.4049/jimmunol.1003153
Hsiao, E. Y., McBride, S. W., Chow, J., Mazmanian, S. K., and Patterson,
P. H. (2012). Modeling an autism risk factor in mice leads to permanent
immune dysregulation. Proc. Natl. Acad. Sci. U.S.A. 109, 12776–12781. doi:
10.1073/pnas.1202556109
Hsiao, E. Y., and Patterson, P. H. (2011). Activation of the maternal immune sys-
tem induces endocrine changes in the placenta via IL-6. Brain Behav. Immun.
25, 604–615. doi: 10.1016/j.bbi.2010.12.017
Ingvorsen, C., Thysen, A. H., Fernandez-Twinn, D., Nordby, P., Nielsen, K. F.,
Ozanne, S. E., et al. (2014). Effects of pregnancy on obesity-induced inflam-
mation in a mouse model of fetal programming. Int. J. Obes. (Lond.). 38,
1282–1289. doi: 10.1038/ijo.2014.69
Irving, W. L., James, D. K., Stephenson, T., Laing, P., Jameson, C., Oxford, J. S.,
et al. (2000). Influenza virus infection in the second and third trimesters of
Frontiers in Neuroscience | www.frontiersin.org 10 February 2015 | Volume 8 | Article 455
Jasoni et al. Gestational inflammation programs disease risk
pregnancy: a clinical and seroepidemiological study. Br. J. Obstet. Gynaecol.
107, 1282–1289. doi: 10.1111/j.1471-0528.2000.tb11621.x
Izumoto, Y., Inoue, S., and Yasuda, N. (1999). Schizophrenia and the influenza
epidemics of 1957 in Japan. Biol. Psychiatry 46, 119–124. doi: 10.1016/S0006-
3223(98)00359-X
Jackson, P., Hougaard, K. S., Vogel, U., Wu, D., Casavant, L., Williams, A., et al.
(2012). Exposure of pregnant mice to carbon black by intratracheal instilla-
tion: Toxicogenomic effects in dams and offspring.Mutat. Res. 745, 73–83. doi:
10.1016/j.mrgentox.2011.09.018
Jackson, P., Vogel, U., Wallin, H., and Hougaard, K. S. (2011). Prenatal expo-
sure to carbon black (Printex 90): Effects on sexual development and neuro-
function. Basic Clin. Pharmacol. Toxicol. 109, 434–437. doi: 10.1111/j.1742-
7843.2011.00745.x
Jeltsch, A., and Jurkowska, R. Z. (2014). New concepts in DNAmethylation. Trends
Biochem. Sci. 39, 310–318. doi: 10.1016/j.tibs.2014.05.002
Jones, H. N., Jansson, T., and Powell, T. L. (2009). IL-6 stimulates system A amino
acid transporter activity in trophoblast cells through STAT3 and increased
expression of SNAT2. Am. J. Physiol. Cell Physiol. 297, C1228–C1235. doi:
10.1152/ajpcell.00195.2009
Kanellopoulos-Langevin, C., Caucheteux, S. M., Verbeke, P., and Ojcius, D. M.
(2003). Tolerance of the fetus by the maternal immune system: role of inflam-
matory mediators at the feto-maternal interface. Reprod. Biol. Endocrinol.
1:121. doi: 10.1186/1477-7827-1-121
Kang, S. S., Kurti, A., Fair, D. A., and Fryer, J. D. (2014). Dietary intervention
rescues maternal obesity induced behavior deficits and neuroinflammation in
offspring. J. Neuroinflammation 11, 156. doi: 10.1186/s12974-014-0156-9
Kent, A. S., Sullivan, M. H., and Elder, M. G. (1994). Transfer of cytokines
through human fetal membranes. J. Reprod. Fertil. 100, 81–84. doi:
10.1530/jrf.0.1000081
Kepczynska, M. A., Wargent, E. T., Cawthorne, M. A., Arch, J. R. S., O’Dowd, J.
F., and Stocker, C. J. (2013). Circulating levels of the cytokines IL10, IFNγ and
resistin in an obese mouse model of developmental programming. J. Dev. Orig.
Health Dis. 4, 491–498. doi: 10.1017/S2040174413000263
Kim, D. W., Young, S. L., Grattan, D. R., and Jasoni, C. L. (2014).Obesity during
pregnancy disrupts placental morphology, cell proliferation, and inflammation
in a sex-specific manner across gestation in the mouse. Biol. Reprod. 90, 130.
doi: 10.1095/biolreprod.113.117259
Kirk, S. L., Samuelsson, A. M., Argenton, M., Dhonye, H., Kalamatianos, T., Pos-
ton, L., et al. (2009). Maternal obesity induced by diet in rats permanently influ-
ences central processes regulating food intake in offspring. PLoS ONE 4:e5870.
doi: 10.1371/journal.pone.0005870
Koch, C. E., Lowe, C., Pretz, D., Steger, J., Williams, L. M., and Tups, A. (2014).
High-fat diet induces leptin resistance in leptin-deficient mice. J. Neuroen-
docrinol. 26, 58–67. doi: 10.1111/jne.12131
Krakowiak, P., Walker, C. K., Bremer, A. A., Baker, A. S., Ozonoff, S., Hansen,
R. L., et al. (2012). Maternal metabolic conditions and risk for autism
and other neurodevelopmental disorders. Pediatrics 129, e1121–e1128. doi:
10.1542/peds.2011-2583
Law, C. M., Barker, D. J., Osmond, C., Fall, C. H., and Simmonds, S. J. (1992). Early
growth and abdominal fatness in adult life. J. Epidemiol. Community Health 46,
184–186. doi: 10.1136/jech.46.3.184
Lee, S., Shen, R., Cho, H. H., Kwon, R. J., Seo, S. Y., Lee, J. W., et al. (2013).
STAT3 promotes motor neuron differentiation by collaborating with motor
neuron-specific LIM complex. Proc. Natl. Acad. Sci. U.S.A. 110, 11445–11450.
doi: 10.1073/pnas.1302676110
Li, M., Reynolds, C. M., Sloboda, D. M., Gray, C., and Vickers, M. H. (2013).
Effects of taurine supplementation on hepatic markers of inflammation and
lipid metabolism in mothers and offspring in the setting of maternal obesity.
PLoS ONE 8:e76961. doi: 10.1371/journal.pone.0076961
Li, P., Spolski, R., Liao, W., and Leonard, W. J. (2014). Complex interactions of
transcription factors in mediating cytokine biology in T cells. Immunol. Rev.
261, 141–156. doi: 10.1111/imr.12199
Li, Y., Deuring, J., Peppelenbosch, M. P., Kuipers, E. J., De Haar, C., and Van Der
Woude, C. J. (2012). IL-6-induced DNMT1 activity mediates SOCS3 promoter
hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis
33, 1889–1896. doi: 10.1093/carcin/bgs214
Lin, H., Mosmann, T. R., Guilbert, L., Tuntipopipat, S., and Wegmann, T. G.
(1993). Synthesis of T helper 2-type cytokines at the maternal-fetal interface.
J. Immunol. 151, 4562–4573.
Linnet, K. M., Dalsgaard, S., Obel, C., Wisborg, K., Henriksen, T. B., Rodriguez,
A., et al. (2003). Maternal lifestyle factors in pregnancy risk of attention deficit
hyperactivity disorder and associated behaviors: review of the current evidence.
Am. J. Psychiatry 160, 1028–1040. doi: 10.1176/appi.ajp.160.6.1028
Madan, J. C., Davis, J. M., Craig, W. Y., Collins, M., Allan, W., Quinn, R., et al.
(2009). Maternal obesity and markers of inflammation in pregnancy. Cytokine
47, 61–64. doi: 10.1016/j.cyto.2009.05.004
Mak, T. W., and Yeh, W. C. (2002). Signaling for survival and apoptosis in the
immune system. Arthritis Res. 4(Suppl 3), S243–S252. doi: 10.1186/ar569
Malassine, A., Frendo, J. L., and Evain-Brion, D. (2003). A comparison of placental
development and endocrine functions between the human and mouse model.
Hum. Reprod. Update 9, 531–539. doi: 10.1093/humupd/dmg043
Malkova, N. V., Yu, C. Z., Hsiao, E. Y., Moore, M. J., and Patterson, P. H. (2012).
Maternal immune activation yields offspring displaying mouse versions of
the three core symptoms of autism. Brain Behav. Immun. 26, 607–616. doi:
10.1016/j.bbi.2012.01.011
Mark, P. J., Lewis, J. L., Jones, M. L., Keelan, J. A., and Waddell, B. J. (2013). The
inflammatory state of the rat placenta increases in late gestation and is further
enhanced by glucocorticoids in the labyrinth zone. Placenta 34, 559–566. doi:
10.1016/j.placenta.2013.04.006
Markham, K., Schuurmans, C., andWeiss, S. (2007). STAT5A/B activity is required
in the developing forebrain and spinal cord. Mol. Cell. Neurosci. 35, 272–282.
doi: 10.1016/j.mcn.2007.03.001
McAllister, D. L., Kaplan, B. J., Edworthy, S. M., Martin, L., Crawford, S. G.,
Ramsey-Goldman, R., et al. (1997). The influence of systemic lupus erythe-
matosus on fetal development: cognitive, behavioral, and health trends. J. Int.
Neuropsychol. Soc. 3, 370–376.
McGrath, J. J., Pemberton, M. R., Welham, J. L., and Murray, R. M. (1994).
Schizophrenia and the influenza epidemics of 1954, 1957 and 1959 – a southern
hemisphere study. Schizophr. Res. 14, 1–8. doi: 10.1016/0920-9964(94)90002-7
Mednick, S. A., Machon, R. A., Huttunen, M. O., and Bonett, D. (1988).
Adult schizophrenia following prenatal exposure to an influenza epi-
demic. Arch. Gen. Psychiatry 45, 189–192. doi: 10.1001/archpsyc.1988.
01800260109013
Meyer, J. M., and Stahl, S. M. (2009). The metabolic syndrome and schizophrenia.
Acta Psychiatr. Scand. 119, 4–14. doi: 10.1111/j.1600-0447.2008.01317.x
Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., and Feldon, J. (2008). Adult
brain and behavioral pathological markers of prenatal immune challenge dur-
ing early/middle and late fetal development in mice. Brain Behav. Immun. 22,
469–486. doi: 10.1016/j.bbi.2007.09.012
Moore, G. S., Kneitel, A. W., Walker, C. K., Gilbert, W. M., and Xing, G. (2012).
Autism risk in small- and large-for-gestational-age infants. Am. J. Obstet.
Gynecol. 206, 314.e1-9. doi: 10.1016/j.ajog.2012.01.044
Mor, G., Cardenas, I., Abrahams, V., and Guller, S. (2011). Inflammation and preg-
nancy: the role of the immune system at the implantation site. Ann. N. Y. Acad.
Sci. 1221, 80–87. doi: 10.1111/j.1749-6632.2010.05938.x
Murray, P. J. (2007). The JAK-STAT signaling pathway: input and output integra-
tion. J. Immunol. 178, 2623–2629. doi: 10.4049/jimmunol.178.5.2623
Nacinovich, R., Galli, J., Bomba, M., Filippini, E., Parrinello, G., Nuzzo, M.,
et al. (2008). Neuropsychological development of children born to patients
with antiphospholipid syndrome. Arthritis Care Res. 59, 345–351. doi:
10.1002/art.23311
Naef, L., Moquin, L., Dal Bo, G., Giros, B., Gratton, A., and Walker, C. D.
(2011). Maternal high-fat intake alters presynaptic regulation of dopamine
in the nucleus accumbens and increases motivation for fat rewards in
the offspring. Neuroscience 176, 225–236. doi: 10.1016/j.neuroscience.2010.
12.037
Naef, L., Srivastava, L., Gratton, A., Hendrickson, H., Owens, S. M., and Walker,
C. D. (2008). Maternal high fat diet during the perinatal period alters meso-
corticolimbic dopamine in the adult rat offspring: reduction in the behavioral
responses to repeated amphetamine administration. Psychopharmacology 197,
83–94. doi: 10.1007/s00213-007-1008-4
Neri, F., Chimini, L., Bonomi, F., Filippini, E., Motta, M., Faden, D.
et al. (2004). Neuropsychological development of children born to patients
with systemic lupus erythematosus. Lupus 13, 805–811. doi: 10.1191/
0961203304lu2018oa
Niculescu, M. D., and Lupu, D. S. (2009). High fat diet-induced maternal obesity
alters fetal hippocampal development. Int. J. Dev. Neurosci. 27, 627–633. doi:
10.1016/j.ijdevneu.2009.08.005
Frontiers in Neuroscience | www.frontiersin.org 11 February 2015 | Volume 8 | Article 455
Jasoni et al. Gestational inflammation programs disease risk
Oken, E., Huh, S. Y., Taveras, E. M., Rich-edwards, J. W., and Gillman, M. W.
(2005). Associations of maternal prenatal smoking with child adiposity and
blood pressure. Obes. Res. 13, 2021–2028. doi: 10.1038/oby.2005.248
Orlebeke, J. F., Knol, D. L., and Verhulst, F. C. (1999). Child behavior problems
increased by maternal smoking during pregnancy. Arch. Environ. Health 54,
15–19. doi: 10.1080/00039899909602231
Ornoy, A. (2011). Prenatal origin of obesity and their complications: Ges-
tational diabetes, maternal overweight and the paradoxical effects of fetal
growth restriction and macrosomia. Reprod. Toxicol. 32, 205–212. doi:
10.1016/j.reprotox.2011.05.002
Pacheco-López, G., Giovanoli, S., Langhans, W., and Meyer, U. (2011). Priming
of metabolic dysfunctions by prenatal immune activation in mice: relevance to
schizophrenia. Schizophr. Bull. 39, 319–329. doi: 10.1093/schbul/sbr178
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., and Fisher, P. B. (2004a).
Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22,
929–979. doi: 10.1146/annurev.immunol.22.012703.104622
Pestka, S., Krause, C. D., and Walter, M. R. (2004b). Interferons, interferon-like
cytokines, and their receptors. Immunol. Rev. 202, 8–32. doi: 10.1111/j.0105-
2896.2004.00204.x
Pohl, J., Luheshi, G. N., and Woodside, B. (2013). Effect of obesity on the acute
inflammatory response in pregnant and cycling female rats. J. Neuroendocrinol.
25, 433–445. doi: 10.1111/jne.12023
Power, C., and Jefferis, B. J. (2002). Fetal environment and subsequent obe-
sity: a study of maternal smoking. Int. J. Epidemiol. 31, 413–419. doi:
10.1093/ije/31.2.413
Qin, S., and Zhang, C. L. (2012). Role of Kruppel-like factor 4 in neurogenesis and
radial neuronal migration in the developing cerebral cortex.Mol. Cell. Biol. 32,
4297–4305. doi: 10.1128/MCB.00838-12
Rajia, S., Chen, H., and Morris, M. J. (2013). Voluntary post weaning exer-
cise restores metabolic homeostasis in offspring of obese rats. Nutr. Metab.
Cardiovasc. Dis. 23, 574–581. doi: 10.1016/j.numecd.2011.12.009
Ravelli, A. C., Van Der Meulen, J. H., Michels, R. P., Osmond, C., Barker, D. J.,
Hales, C. N., et al. (1998). Glucose tolerance in adults after prenatal exposure to
famine. Lancet 351, 173–177. doi: 10.1016/S0140-6736(97)07244-9
Ravelli, G. P., Stein, Z. A., and Susser, M. W. (1976). Obesity in young men after
famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353. doi:
10.1056/NEJM197608122950701
Roberts, K. A., Riley, S. C., Reynolds, R. M., Barr, S., Evans, M., Statham, A., et al.
(2011). Placental structure and inflammation in pregnancies associated with
obesity. Placenta 32, 247–254. doi: 10.1016/j.placenta.2010.12.023
Roberts, V. H., Pound, L. D., Thorn, S. R., Gillingham, M. B., Thornburg, K. L.,
Friedman, J. E., et al. (2014). Beneficial and cautionary outcomes of resveratrol
supplementation in pregnant nonhuman primates. FASEB J. 28, 2466–2477.
doi: 10.1096/fj.13-245472
Rodriguez, A. (2010). Maternal pre-pregnancy obesity and risk for inattention and
negative emotionality in children. J. Child Psychol. Psychiatry 51, 134–143. doi:
10.1111/j.1469-7610.2009.02133.x
Roseboom, T. J., Van Der Meulen, J. H., Osmond, C., Barker, D. J., Ravelli,
A. C., Schroeder-Tanka, J. M., et al. (2000). Coronary heart disease after
prenatal exposure to the Dutch famine, 1944–45. Heart 84, 595–598. doi:
10.1136/heart.84.6.595
Ross, G., Sammaritano, L., Nass, R., and Lockshin, M. (2003). Effects of moth-
ers’ autoimmune disease during pregnancy on learning disabilities and hand
preference in their children. Arch. Pediatr. Adolesc. Med. 157, 397–402. doi:
10.1001/archpedi.157.4.397
Ryan, M. C., Collins, P., and Thakore, J. H. (2003). Impaired fasting glucose toler-
ance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry
160, 284–289. doi: 10.1176/appi.ajp.160.2.284
Saijo, K., and Glass, C. K. (2011). Microglial cell origin and phenotypes in health
and disease. Nat. Rev. Immunol. 11, 775–787. doi: 10.1038/nri3086
Sanders, T. R., Kim, D. W., Glendining, K. A., and Jasoni, C. L. (2014). Maternal
obesity and IL-6 lead to aberrant developmental gene expression and deregu-
lated neurite growth in the fetal arcuate nucleus. Endocrinology 155, 2566–2577.
doi: 10.1210/en.2013-1968
Sasaki, A., De Vega, W., Sivanathan, S., St-Cyr, S., and McGowan, P.
(2014). Maternal high-fat diet alters anxiety behavior and glucocorti-
coid signaling in adolescent offspring. Neuroscience 272C, 92–101. doi:
10.1016/j.neuroscience.2014.04.012
Schwarting, G. A., Henion, T. R., Nugent, J. D., Caplan, B., and Tobet, S.
(2006). Stromal cell-derived factor-1 (chemokine C-X-C motif ligand 12) and
chemokine C-X-Cmotif receptor 4 are required formigration of gonadotropin-
releasing hormone neurons to the forebrain. J. Neurosci. 26, 6834–6840. doi:
10.1523/JNEUROSCI.1728-06.2006
Shi, L. M., Tu, N., and Patterson, P. H. (2005). Maternal influenza infection is likely
to alter fetal brain development indirectly: the virus is not detected in the fetus.
Int. J. Dev. Neurosci. 23, 299–305. doi: 10.1016/j.ijdevneu.2004.05.005
Smith, S. E., Li, J., Garbett, K., Mirnics, K., and Patterson, P. H. (2007). Mater-
nal immune activation alters fetal brain development through interleukin-6.
J. Neurosci. 27, 10695–10702. doi: 10.1523/JNEUROSCI.2178-07.2007
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G.,
et al. (2011). Interleukin-6, a mental cytokine. Brain Res. Rev. 67, 157–183. doi:
10.1016/j.brainresrev.2011.01.002
Stanley, B. G., and Leibowitz, S. F. (1984). Neuropeptide Y: stimulation of feed-
ing and drinking by injection into the paraventricular nucleus. Life sciences 35,
2635–2642. doi: 10.1016/0024-3205(84)90032-8
Steinborn, A., Geisse, M., and Kaufmann, M. (1998). Expression of cytokine recep-
tors in the placenta in term and preterm labour. Placenta 19, 165–170. doi:
10.1016/S0143-4004(98)90005-4
Steinborn, A., Gunes, H., and Halberstadt, E. (1995). Signal for term parturition
is of trophoblast and therefore of fetal origin. Prostaglandins 50, 237–252. doi:
10.1016/0090-6980(95)00138-7
Stewart, F. M., Freeman, D. J., Ramsay, J. E., Greer, I. A., Caslake, M., and
Ferrell, W. R. (2007). Longitudinal assessment of maternal endothelial func-
tion and markers of inflammation and placental function throughout preg-
nancy in lean and obese mothers. J. Clin. Endocrinol. Metab. 92, 969–975. doi:
10.1210/jc.2006-2083
Suzuki, T., Oshio, S., Iwata, M., Saburi, H., Odagiri, T., Udagawa, T., et al. (2010).
In utero exposure to a low concentration of diesel exhaust affects sponta-
neous locomotor activity and monoaminergic system in male mice. Part. Fibre
Toxicol. 7:7. doi: 10.1186/1743-8977-7-7
Tamashiro, K. L., and Moran, T. H. (2010). Perinatal environment and its influ-
ences on metabolic programming of offspring. Physiol. Behav. 100, 560–566.
doi: 10.1016/j.physbeh.2010.04.008
Tang, D., Li, T. Y., Liu, J. J., Zhou, Z. J., Yuan, T., Chen, Y. H., et al. (2008).
Effects of prenatal exposure to coal-burning pollutants on children’s devel-
opment in China. Environ. Health Perspect. 116, 674–679. doi: 10.1289/
ehp.10471
Thakore, J. H. (2004). Metabolic disturbance in first-episode schizophrenia. Br. J.
Psychiatry 184, s76–s79. doi: 10.1192/bjp.184.47.s76
Toschke, A. M., Montgomery, S. M., Pfeiffer, U., and Von Kries, R. (2003).
Early intrauterine exposure to tobacco-inhaled products and obesity. Am. J.
Epidemiol. 158, 1068–1074. doi: 10.1093/aje/kwg258
Tozuka, Y., Kumon, M., Wada, E., Onodera, M., Mochizuki, H., and Wada, K.
(2010). Maternal obesity impairs hippocampal BDNF production and spatial
learning performance in young mouse offspring. Neurochem. Int. 57, 235–247.
doi: 10.1016/j.neuint.2010.05.015
Tozuka, Y., Wada, E., and Wada, K. (2009). Diet-induced obesity in female mice
leads to peroxidized lipid accumulations and impairment of hippocampal neu-
rogenesis during the early life of their offspring. FASEB J. 23, 1920–1934. doi:
10.1096/fj.08-124784
Urayama, S., Semi, K., Sanosaka, T., Hori, Y., Namihira, M., Kohyama, J.,
et al. (2013). Chromatin accessibility at a STAT3 target site is altered prior
to astrocyte differentiation. Cell Struct. Funct. 38, 55–66. doi: 10.1247/csf.
12034
Vahedi, G., Takahashi, H., Nakayamada, S., Sun, H. W., Sartorelli, V., Kanno, Y.,
et al. (2012). STATs shape the active enhancer landscape of T cell populations.
Cell 151, 981–993. doi: 10.1016/j.cell.2012.09.044
Van Lieshout, R. J., and Boyle, M. H. (2011a). Canadian youth born large or
small for gestational age and externalizing and internalizing problems. Can. J.
psychiatry 56, 227–234.
Van Lieshout, R. J., and Boyle, M. H. (2011b). Is bigger better? macrosomia and
psychopathology later in life. Obes. Rev. 12, e405–e411. doi: 10.1111/j.1467-
789X.2010.00816.x
Watson, E. D., and Cross, J. C. (2005). Development of structures and transport
functions in the mouse placenta. Physiology 20, 180–193. doi: 10.1152/phys-
iol.00001.2005
Frontiers in Neuroscience | www.frontiersin.org 12 February 2015 | Volume 8 | Article 455
Jasoni et al. Gestational inflammation programs disease risk
Williams, K., andMackenzie, J. S. (1977). Influenza infections during pregnancy in
the mouse. J. Hyg. 79, 249–257. doi: 10.1017/S0022172400053067
Wojcik, W., Lee, W., Colman, I., Hardy, R., and Hotopf, M. (2013). Foetal
origins of depression? A systematic review and meta-analysis of low
birth weight and later depression. Psychol. Med. 43, 1–12. doi: 10.1017/
S0033291712000682
Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., and Wouters,
E. F. (2007). Systemic effects of smoking. Chest J. 131, 1557–1566. doi:
10.1378/chest.06-2179
Zaretsky, M. V., Alexander, J. M., Byrd, W., and Bawdon, R. E. (2004). Transfer of
inflammatory cytokines across the placenta.Obstet. Gynecol. 103, 546–550. doi:
10.1097/01.AOG.0000114980.40445.83
Zhang, L., Sugiyama, T., Murabayashi, N., Umekawa, T., Ma, N., Kamimoto, Y.,
et al. (2011). The inflammatory changes of adipose tissue in late pregnant mice.
J. Mol. Endocrinol. 47, 157–165. doi: 10.1530/JME-11-0030
Zhu, M. J., Du, M., Nathanielsz, P. W., and Ford, S. P. (2010). Maternal obe-
sity up-regulates inflammatory signaling pathways and enhances cytokine
expression in the mid-gestation sheep placenta. Placenta 31, 387–391. doi:
10.1016/j.placenta.2010.02.002
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Jasoni, Sanders and Kim. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this jour-
nal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 13 February 2015 | Volume 8 | Article 455
